Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday ... 2024 Healthcare & ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.

Inovio Pharmaceuticals Inc.-3.56% $138.65M ...

Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for ...

In a media briefing streamed live on Canada's Global News, Bonnie Henry, MD, BC's health officer, shared the latest investigation findings ... She said initial symptoms included conjunctivitis, fever, ...

Aerobic exercise has been linked with Parkinson's disease progression and risk. (Washington Post) Air purifiers in ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...

A trial participant developed amytrophic lateral sclerosis (ALS), an event deemed unrelated to vaccination. Novavax’s shares jumped in pre-market trading on the news but settled once markets opened.

If you missed the early fall push for flu and COVID-19 vaccines, it's not too late.Health officials say it's important to get ...

and Novavax says additional data – including on manufacturing – will be submitted in the second quarter. A US trial is also ongoing and should read out in a few weeks. UK Health Secretary Matt ...

Novavax’s COVID-19 vaccine produced higher ... There are 26 potential vaccine candidates in clinical trials, according to the World Health Organization’s reckoning, with the most advanced ...